1	M-CSF	_	NN	_	_	2	VMOD	_	_
2	signals	_	VBZ	_	_	0	ROOT	_	_
3	through	_	IN	_	_	2	VMOD	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	MAPK/ERK	_	NN	_	_	6	NMOD	_	_
6	pathway	_	NN	_	_	3	PMOD	_	_
7	via	_	IN	_	_	6	NMOD	_	_
8	Sp1	_	NN	_	_	7	PMOD	_	_
9	to	_	TO	_	_	6	APPO	_	_
10	induce	_	VB	_	_	9	IM	_	_
11	VEGF	_	NN	_	_	12	NMOD	_	_
12	production	_	NN	_	_	10	VMOD	_	_
13	and	_	CC	_	_	2	COORD	_	_
14	induces	_	VBZ	_	_	13	CONJ	_	_
15	angiogenesis	_	NN	_	_	14	VMOD	_	_
16	in	_	FW	_	_	14	VMOD	_	_
17	vivo	_	FW	_	_	16	AMOD	_	_
18	.	_	.	_	_	2	P	_	_
		
1	BACKGROUND	_	NN	_	_	0	ROOT	_	_
2	:	_	:	_	_	1	P	_	_
3	M-CSF	_	NN	_	_	4	VMOD	_	_
4	recruits	_	VBZ	_	_	1	NMOD	_	_
5	mononuclear	_	JJ	_	_	6	NMOD	_	_
6	phagocytes	_	NNS	_	_	4	VMOD	_	_
7	which	_	WDT	_	_	8	VMOD	_	_
8	regulate	_	VBP	_	_	6	NMOD	_	_
9	processes	_	NNS	_	_	8	VMOD	_	_
10	such	_	JJ	_	_	11	DEP	_	_
11	as	_	IN	_	_	9	NMOD	_	_
12	angiogenesis	_	NN	_	_	11	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	metastases	_	NNS	_	_	13	CONJ	_	_
15	in	_	IN	_	_	12	NMOD	_	_
16	tumors	_	NNS	_	_	15	PMOD	_	_
17	.	_	.	_	_	1	P	_	_
		
1	VEGF	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	5	NMOD	_	_
4	potent	_	JJ	_	_	5	NMOD	_	_
5	activator	_	NN	_	_	2	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	angiogenesis	_	NN	_	_	6	PMOD	_	_
8	as	_	IN	_	_	2	VMOD	_	_
9	it	_	PRP	_	_	10	VMOD	_	_
10	promotes	_	VBZ	_	_	8	SUB	_	_
11	endothelial	_	JJ	_	_	13	NMOD	_	_
12	cell	_	NN	_	_	13	NMOD	_	_
13	proliferation	_	NN	_	_	10	VMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	new	_	JJ	_	_	18	NMOD	_	_
16	blood	_	NN	_	_	18	NMOD	_	_
17	vessel	_	NN	_	_	18	NMOD	_	_
18	formation	_	NN	_	_	14	CONJ	_	_
19	.	_	.	_	_	2	P	_	_
		
1	Previously	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	reported	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	in	_	FW	_	_	7	AMOD	_	_
7	vitro	_	FW	_	_	8	NMOD	_	_
8	M-CSF	_	NN	_	_	9	VMOD	_	_
9	induces	_	VBZ	_	_	5	SUB	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	expression	_	NN	_	_	9	VMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	biologically-active	_	JJ	_	_	14	NMOD	_	_
14	VEGF	_	NN	_	_	12	PMOD	_	_
15	from	_	IN	_	_	11	NMOD	_	_
16	human	_	JJ	_	_	17	NMOD	_	_
17	monocytes	_	NNS	_	_	15	PMOD	_	_
18	.	_	.	_	_	4	P	_	_
		
1	METHODOLOGY	_	NN	_	_	0	ROOT	_	_
2	AND	_	CC	_	_	1	COORD	_	_
3	RESULTS	_	NNS	_	_	2	CONJ	_	_
4	:	_	:	_	_	1	P	_	_
5	In	_	IN	_	_	10	VMOD	_	_
6	this	_	DT	_	_	7	NMOD	_	_
7	study	_	NN	_	_	5	PMOD	_	_
8	,	_	,	_	_	10	P	_	_
9	we	_	PRP	_	_	10	VMOD	_	_
10	demonstrate	_	VBP	_	_	1	NMOD	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	molecular	_	JJ	_	_	13	NMOD	_	_
13	mechanism	_	NN	_	_	10	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	M-CSF-induced	_	JJ	_	_	17	NMOD	_	_
16	VEGF	_	NN	_	_	17	NMOD	_	_
17	production	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	1	P	_	_
		
1	Using	_	VBG	_	_	15	VMOD	_	_
2	a	_	DT	_	_	3	NMOD	_	_
3	construct	_	NN	_	_	1	VMOD	_	_
4	containing	_	VBG	_	_	3	APPO	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	VEGF	_	NN	_	_	7	NMOD	_	_
7	promoter	_	NN	_	_	4	VMOD	_	_
8	linked	_	VBN	_	_	7	APPO	_	_
9	to	_	TO	_	_	8	VMOD	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	luciferase	_	NN	_	_	12	NMOD	_	_
12	reporter	_	NN	_	_	9	PMOD	_	_
13	,	_	,	_	_	15	P	_	_
14	we	_	PRP	_	_	15	VMOD	_	_
15	found	_	VBD	_	_	0	ROOT	_	_
16	that	_	IN	_	_	15	VMOD	_	_
17	a	_	DT	_	_	20	NMOD	_	_
18	mutation	_	NN	_	_	20	NMOD	_	_
19	reducing	_	NN	_	_	20	NMOD	_	_
20	HIF	_	NN	_	_	26	VMOD	_	_
21	binding	_	VBG	_	_	20	APPO	_	_
22	to	_	TO	_	_	21	VMOD	_	_
23	the	_	DT	_	_	25	NMOD	_	_
24	VEGF	_	NN	_	_	25	NMOD	_	_
25	promoter	_	NN	_	_	22	PMOD	_	_
26	had	_	VBD	_	_	16	SUB	_	_
27	no	_	DT	_	_	29	NMOD	_	_
28	significant	_	JJ	_	_	29	NMOD	_	_
29	effect	_	NN	_	_	26	VMOD	_	_
30	on	_	IN	_	_	26	VMOD	_	_
31	luciferase	_	NN	_	_	32	NMOD	_	_
32	production	_	NN	_	_	30	PMOD	_	_
33	induced	_	VBN	_	_	32	APPO	_	_
34	by	_	IN	_	_	33	VMOD	_	_
35	M-CSF	_	NN	_	_	36	NMOD	_	_
36	stimulation	_	NN	_	_	34	PMOD	_	_
37	.	_	.	_	_	15	P	_	_
		
1	Further	_	JJ	_	_	2	NMOD	_	_
2	analysis	_	NN	_	_	3	VMOD	_	_
3	revealed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	M-CSF	_	NN	_	_	6	VMOD	_	_
6	induced	_	VBD	_	_	4	SUB	_	_
7	VEGF	_	NN	_	_	6	VMOD	_	_
8	through	_	IN	_	_	6	VMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	MAPK/ERK	_	NN	_	_	12	NMOD	_	_
11	signaling	_	NN	_	_	12	NMOD	_	_
12	pathway	_	NN	_	_	8	PMOD	_	_
13	via	_	IN	_	_	6	VMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	transcription	_	NN	_	_	16	NMOD	_	_
16	factor	_	NN	_	_	13	PMOD	_	_
17	,	_	,	_	_	16	P	_	_
18	Sp1	_	NN	_	_	16	APPO	_	_
19	.	_	.	_	_	3	P	_	_
		
1	Thus	_	RB	_	_	9	VMOD	_	_
2	,	_	,	_	_	9	P	_	_
3	inhibition	_	NN	_	_	9	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	either	_	CC	_	_	6	DEP	_	_
6	ERK	_	NN	_	_	4	PMOD	_	_
7	or	_	CC	_	_	6	COORD	_	_
8	Sp1	_	NN	_	_	7	CONJ	_	_
9	suppressed	_	VBD	_	_	0	ROOT	_	_
10	M-CSF-induced	_	JJ	_	_	11	NMOD	_	_
11	VEGF	_	NN	_	_	9	VMOD	_	_
12	at	_	IN	_	_	9	VMOD	_	_
13	the	_	DT	_	_	17	NMOD	_	_
14	mRNA	_	NN	_	_	17	NMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	protein	_	NN	_	_	15	CONJ	_	_
17	level	_	NN	_	_	12	PMOD	_	_
18	.	_	.	_	_	9	P	_	_
		
1	M-CSF	_	NN	_	_	3	VMOD	_	_
2	also	_	RB	_	_	3	VMOD	_	_
3	induced	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	nuclear	_	JJ	_	_	6	NMOD	_	_
6	localization	_	NN	_	_	3	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	Sp1	_	NN	_	_	7	PMOD	_	_
9	,	_	,	_	_	3	P	_	_
10	which	_	WDT	_	_	11	VMOD	_	_
11	was	_	VBD	_	_	3	VMOD	_	_
12	blocked	_	VBN	_	_	11	VC	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	ERK	_	NN	_	_	15	NMOD	_	_
15	inhibition	_	NN	_	_	13	PMOD	_	_
16	.	_	.	_	_	3	P	_	_
		
1	Finally	_	RB	_	_	15	VMOD	_	_
2	,	_	,	_	_	15	P	_	_
3	mutating	_	VBG	_	_	15	VMOD	_	_
4	the	_	DT	_	_	7	NMOD	_	_
5	Sp1	_	NN	_	_	7	NMOD	_	_
6	binding	_	NN	_	_	7	NMOD	_	_
7	sites	_	NNS	_	_	3	VMOD	_	_
8	within	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	VEGF	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	8	PMOD	_	_
12	or	_	CC	_	_	3	COORD	_	_
13	inhibiting	_	VBG	_	_	12	CONJ	_	_
14	ERK	_	NN	_	_	13	VMOD	_	_
15	decreased	_	VBD	_	_	0	ROOT	_	_
16	VEGF	_	NN	_	_	18	NMOD	_	_
17	promoter	_	NN	_	_	18	NMOD	_	_
18	activity	_	NN	_	_	15	VMOD	_	_
19	in	_	IN	_	_	18	NMOD	_	_
20	M-CSF-treated	_	JJ	_	_	22	NMOD	_	_
21	human	_	JJ	_	_	22	NMOD	_	_
22	monocytes	_	NNS	_	_	19	PMOD	_	_
23	.	_	.	_	_	15	P	_	_
		
1	To	_	TO	_	_	13	VMOD	_	_
2	evaluate	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	biological	_	JJ	_	_	5	NMOD	_	_
5	significance	_	NN	_	_	2	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	M-CSF	_	NN	_	_	10	NMOD	_	_
8	induced	_	JJ	_	_	10	NMOD	_	_
9	VEGF	_	NN	_	_	10	NMOD	_	_
10	production	_	NN	_	_	6	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	we	_	PRP	_	_	13	VMOD	_	_
13	used	_	VBD	_	_	0	ROOT	_	_
14	an	_	DT	_	_	18	NMOD	_	_
15	in	_	FW	_	_	16	AMOD	_	_
16	vivo	_	FW	_	_	18	NMOD	_	_
17	angiogenesis	_	NN	_	_	18	NMOD	_	_
18	model	_	NN	_	_	13	VMOD	_	_
19	to	_	TO	_	_	13	VMOD	_	_
20	illustrate	_	VBP	_	_	19	IM	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	ability	_	NN	_	_	20	VMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	M-CSF	_	NN	_	_	23	PMOD	_	_
25	to	_	TO	_	_	22	NMOD	_	_
26	recruit	_	VB	_	_	25	IM	_	_
27	mononuclear	_	JJ	_	_	28	NMOD	_	_
28	phagocytes	_	NNS	_	_	26	VMOD	_	_
29	,	_	,	_	_	26	P	_	_
30	increase	_	VB	_	_	26	COORD	_	_
31	VEGF	_	NN	_	_	32	NMOD	_	_
32	levels	_	NNS	_	_	30	VMOD	_	_
33	,	_	,	_	_	30	P	_	_
34	and	_	CC	_	_	30	COORD	_	_
35	enhance	_	VB	_	_	34	CONJ	_	_
36	angiogenesis	_	NN	_	_	35	VMOD	_	_
37	.	_	.	_	_	13	P	_	_
		
1	Importantly	_	RB	_	_	10	VMOD	_	_
2	,	_	,	_	_	10	P	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	addition	_	NN	_	_	10	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	a	_	DT	_	_	9	NMOD	_	_
7	neutralizing	_	VBG	_	_	9	NMOD	_	_
8	VEGF	_	NN	_	_	9	NMOD	_	_
9	antibody	_	NN	_	_	5	PMOD	_	_
10	abolished	_	VBD	_	_	0	ROOT	_	_
11	M-CSF-induced	_	JJ	_	_	14	NMOD	_	_
12	blood	_	NN	_	_	14	NMOD	_	_
13	vessel	_	NN	_	_	14	NMOD	_	_
14	formation	_	NN	_	_	10	VMOD	_	_
15	.	_	.	_	_	10	P	_	_
		
1	CONCLUSION	_	NN	_	_	0	ROOT	_	_
2	:	_	:	_	_	1	P	_	_
3	These	_	DT	_	_	4	NMOD	_	_
4	data	_	NNS	_	_	5	VMOD	_	_
5	delineate	_	VBP	_	_	1	NMOD	_	_
6	an	_	DT	_	_	10	NMOD	_	_
7	ERK-	_	JJ	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	Sp1-dependent	_	JJ	_	_	8	CONJ	_	_
10	mechanism	_	NN	_	_	5	VMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	M-CSF	_	NN	_	_	15	NMOD	_	_
13	induced	_	JJ	_	_	15	NMOD	_	_
14	VEGF	_	NN	_	_	15	NMOD	_	_
15	production	_	NN	_	_	11	PMOD	_	_
16	and	_	CC	_	_	5	COORD	_	_
17	demonstrate	_	VBP	_	_	16	CONJ	_	_
18	for	_	IN	_	_	17	VMOD	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	first	_	JJ	_	_	21	NMOD	_	_
21	time	_	NN	_	_	18	PMOD	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	ability	_	NN	_	_	17	VMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	M-CSF	_	NN	_	_	24	PMOD	_	_
26	to	_	TO	_	_	23	NMOD	_	_
27	induce	_	VB	_	_	26	IM	_	_
28	angiogenesis	_	NN	_	_	27	VMOD	_	_
29	via	_	IN	_	_	27	VMOD	_	_
30	VEGF	_	NN	_	_	29	PMOD	_	_
31	in	_	FW	_	_	27	VMOD	_	_
32	vivo	_	FW	_	_	31	AMOD	_	_
33	.	_	.	_	_	1	P	_	_
		
